SELENOS and neoplasm: The use of leishmanial selenoproteins inhibitors as well as the anti-tumour property of selenoproteins and their metabolites against cancer cells might suggest that such aforementioned compounds represent therapeutic targets for the treatment of leishmaniasis and cancers.